MARKET WIRE NEWS
  1. Home
  2. Stock
  3. ESPR
  4. News
ESPR
Quote
Short
News
Articles
Message Board

Esperion Therapeutics Inc. (NASDAQ : ESPR ) News

Esperion Therapeutics Inc. (NASDAQ: ESPR) News Releases

ESPR News Releases
ESPR : NASDAQ
GlobeNewswire
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology's Annual Scientific Session 2026
ESPR : NASDAQ
GlobeNewswire
Esperion to Present Two New Analyses from CLEAR Outcomes Clinical Trial at the American College of Cardiology 2026 Annual Scientific Session
ESPR : NASDAQ
GlobeNewswire
Esperion's Bempedoic Acid Receives Multiple Class 1 Recommendations in 2026 ACC/AHA Multisociety Guideline for Management of Dyslipidemia
ESPR : NASDAQ
SeekingAlpha
Esperion outlines Vision 2040 with Corstasis acquisition and targets 2026 operating expenses up to $255M while expanding cardiometabolic portfolio
ESPR : NASDAQ
SeekingAlpha
Esperion Therapeutics, Inc. (ESPR) Q4 2025 Earnings Call Transcript
ESPR : NASDAQ
US Earnings Reports
Expected US Company Earnings on Tuesday, March 10th, 2026
ESPR : NASDAQ
SeekingAlpha
Esperion Therapeutics GAAP EPS of $0.22 misses by $0.05, revenue of $168.45M beats by $2.33M
ESPR : NASDAQ
GlobeNewswire
Esperion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
ESPR : NASDAQ
KlickAnalytics
ESPR - Historical Price Movements Surrounding Earnings
ESPR : NASDAQ
SeekingAlpha
Esperion Therapeutics Q4 2025 Earnings Preview
Back to Start Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.